Synopsis The safety, efficacy, benefit and the duration of anticoagulant treatment in Portal vein thrombosis (PVT) is a controversial issue. Thus, the present study aimed to analyze the course of PVT in cirrhotic patients who are undergoing or not undergoing anticoagulation therapy. This Journal Watch discusses a clinical trial from The American Journal of Gastroenterology, “Clinical Impact and Safety of Anticoagulants for Portal Vein Thrombosis in Cirrhosis”.
Authors: Pettinari, I., et al. Key Takeaways Anticoagulant treatment lead to partial or complete recanalization of the portal venous system in 56.8% of cases, improving cirrhosis and PVT Objective: To assess Safety And Efficacy Of Anticoagulants For Portal vein thrombosis In Cirrhosis Study Type: Randomized Controlled Trial Participants: 182 What Was The Need For This Study? Portal vein thrombosis (PVT) is a frequent complication…
